Search Results - "Parsons, M F C"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    The in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer by Parsons, M F C, Foster, P A, Chander, S K, Jhalli, R, Newman, S P, Leese, M P, Potter, B V L, Purohit, A, Reed, M J

    Published in British journal of cancer (04-11-2008)
    “…The steroidal-based drug 2-ethyloestradiol-3,17- O , O - bis -sulphamate (STX243) has been developed as a potent antiangiogenic and antitumour compound. The…”
    Get full text
    Journal Article
  2. 2

    Inhibition of Steroid Sulphatase Activity via the Percutaneous Route: A New Option for Breast Cancer Therapy by PUROHIT, A, CHANDER, S. K, WOO, L. W. L, PARSONS, M. F. C, JHALLI, R, POTTER, B. V. L, REED, M. J

    Published in Anticancer research (01-05-2008)
    “…Steroid sulphatase (STS) inhibitors have been developed primarily for the treatment of hormone-dependent breast cancer, but may also have utility for the…”
    Get full text
    Journal Article
  3. 3

    Tibolone and its delta-4, 7α-methyl norethisterone metabolite are reversible inhibitors of human aromatase by Raobaikady, B., Parsons, M.F.C., Reed, M.J., Purohit, A.

    “…Tibolone is used for the treatment of climacteric symptoms and osteoporosis in menopausal women. After ingestion, it is rapidly converted to a number of…”
    Get full text
    Journal Article
  4. 4

    Tibolone and its delta-4, 7alpha-methyl norethisterone metabolite are reversible inhibitors of human aromatase by Raobaikady, B, Parsons, M F C, Reed, M J, Purohit, A

    “…Tibolone is used for the treatment of climacteric symptoms and osteoporosis in menopausal women. After ingestion, it is rapidly converted to a number of…”
    Get full text
    Journal Article